TRACON Pharmaceuticals, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
TRACON Pharmaceuticals, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$6.01 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2024-08-13
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$2.84M.
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$3.17M.
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was $439.00K.
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-09-30 was $10.76M.
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$3.59M.
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$29.14M.
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$28.67M.
- TRACON Pharmaceuticals, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$16.77M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$6.01M 10-Q · filed 2024-08-13 | -$5.57M derived: sum of 3 quarters · filed 2024-08-13 | $5.20M derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | -$3.17M 10-Q · filed 2024-05-14 | -$2.73M derived: sum of 2 quarters · filed 2024-05-14 | $8.03M derived: sum of 3 quarters · filed 2024-05-14 | $1.75M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $11.20M derived: sum of 2 quarters · filed 2024-03-05 | $4.92M derived: sum of 3 quarters · filed 2024-08-13 | -$3.59M 10-K · filed 2024-03-05 |
| 2023-09-30 | $10.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $4.48M derived: sum of 2 quarters · filed 2024-08-13 | -$4.03M 10-Q · filed 2023-11-09 | -$11.02M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-06-30 | -$6.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$14.79M 10-Q · filed 2024-08-13 | -$21.79M derived: sum of 3 quarters · filed 2024-08-13 | -$28.22M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$8.50M 10-Q · filed 2024-05-14 | -$15.50M derived: sum of 2 quarters · filed 2024-05-14 | -$21.94M derived: sum of 3 quarters · filed 2024-05-14 | -$28.17M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$13.43M derived: sum of 2 quarters · filed 2024-03-05 | -$19.66M derived: sum of 3 quarters · filed 2024-03-05 | -$29.14M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$12.66M derived: sum of 2 quarters · filed 2023-11-09 | -$22.14M 10-Q · filed 2023-11-09 | -$29.85M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$6.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$15.70M 10-Q · filed 2023-08-14 | -$23.41M derived: sum of 3 quarters · filed 2024-03-05 | -$30.37M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$9.47M 10-Q · filed 2023-05-10 | -$17.18M derived: sum of 2 quarters · filed 2024-03-05 | -$24.14M derived: sum of 3 quarters · filed 2024-03-05 | -$33.08M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$14.66M derived: sum of 2 quarters · filed 2024-03-05 | -$23.60M derived: sum of 3 quarters · filed 2024-03-05 | -$28.67M 10-K · filed 2024-03-05 |
| 2021-09-30 | -$6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$15.89M derived: sum of 2 quarters · filed 2022-11-14 | -$20.95M 10-Q · filed 2022-11-14 | -$25.27M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | -$8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$14.00M 10-Q · filed 2022-08-10 | -$18.31M derived: sum of 3 quarters · filed 2023-03-08 | -$22.31M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | -$5.06M 10-Q · filed 2022-05-11 | -$9.38M derived: sum of 2 quarters · filed 2023-03-08 | -$13.37M derived: sum of 3 quarters · filed 2023-03-08 | -$17.82M derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | -$4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$8.30M derived: sum of 2 quarters · filed 2023-03-08 | -$12.75M derived: sum of 3 quarters · filed 2023-03-08 | -$16.77M 10-K · filed 2023-03-08 |
| 2020-09-30 | -$3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$8.44M derived: sum of 2 quarters · filed 2021-11-03 | -$12.46M 10-Q · filed 2021-11-03 | -$16.40M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$8.47M 10-Q · filed 2021-08-11 | -$12.41M derived: sum of 3 quarters · filed 2022-03-15 | -$17.61M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | -$4.02M 10-Q · filed 2021-05-05 | -$7.96M derived: sum of 2 quarters · filed 2022-03-15 | -$13.16M derived: sum of 3 quarters · filed 2022-03-15 | -$19.48M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | -$3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$9.13M derived: sum of 2 quarters · filed 2022-03-15 | -$15.46M derived: sum of 3 quarters · filed 2022-03-15 | -$22.67M 10-K · filed 2022-03-15 |
| 2019-09-30 | -$5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$11.53M derived: sum of 2 quarters · filed 2020-11-10 | -$18.74M 10-Q · filed 2020-11-10 | -$26.49M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$6.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$13.54M 10-Q · filed 2020-08-05 | -$21.30M derived: sum of 3 quarters · filed 2021-02-25 | -$30.38M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$7.21M 10-Q · filed 2020-05-13 | -$14.97M derived: sum of 2 quarters · filed 2021-02-25 | -$24.05M derived: sum of 3 quarters · filed 2021-02-25 | -$33.81M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$7.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$16.84M derived: sum of 2 quarters · filed 2021-02-25 | -$26.59M derived: sum of 3 quarters · filed 2021-02-25 | -$34.96M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$9.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$18.84M derived: sum of 2 quarters · filed 2019-11-05 | -$27.20M 10-Q · filed 2019-11-05 | -$33.76M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$9.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$18.12M 10-Q · filed 2019-08-07 | -$24.68M derived: sum of 3 quarters · filed 2020-02-28 | |
| 2018-03-31 | -$8.36M 10-Q · filed 2019-05-14 | -$14.92M derived: sum of 2 quarters · filed 2020-02-28 | ||
| 2017-12-31 | -$6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$19.10M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | -$12.54M 10-Q · filed 2018-11-07 | |||
| 2016-12-31 | -$27.01M 10-K · filed 2019-03-01 |